Possible Risk of Invasive Pulmonary Aspergillosis with Marijuana Use during Chemotherapy for Small Cell Lung Cancer
- 1 April 1986
- journal article
- case report
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 20 (4) , 289-291
- https://doi.org/10.1177/106002808602000416
Abstract
Bacterial and fungal contaminants have been identified in marijuana samples and thus are a potential risk factor in the immunocompromised patient using it as an antiemetic. We describe the development of an invasive pulmonary aspergillosis in a patient using illicitly obtained marijuana as an antiemetic during combination antitumor therapy for small cell lung cancer. Although this patient had multiple risk factors implicated in the development of invasive pulmonary aspergillosis, the infectious potential of inhaled marijuana must be recognized. Further study of this potential health risk is needed.Keywords
This publication has 16 references indexed in Scilit:
- Opportunistic fungal infections in patients with neoplastic diseaseThe American Journal of Medicine, 1984
- Salmonellosis Associated with MarijuanaNew England Journal of Medicine, 1982
- Fungal Pneumonia (Part 4)Chest, 1981
- Aspergillus: An Inhalable Contaminant of MarihuanaNew England Journal of Medicine, 1981
- Invasive Aspergillosis in Acute Leukemia: Correlation with Nose Cultures and Antibiotic UseAnnals of Internal Medicine, 1979
- Allergic Bronchopulmonary Aspergillosis Associated with Smoking Moldy MarihuanaChest, 1978
- Intact humoral and cell-mediated immunity in chronic marijuana smokingJournal of Allergy and Clinical Immunology, 1976
- Marihuana, tetrahydrocannabinol and T-cell functionLife Sciences, 1976
- Pulmonary Aspergillosis, Inhalation of Contaminated Marijuana Smoke, Chronic Granulomatous DiseaseAnnals of Internal Medicine, 1975
- The Compromised Host and Infection. II. Deep Fungal InfectionThe Journal of Infectious Diseases, 1969